Abstract
We welcome the opportunity to respond to the commentaries on our paper—The Mouse that Trolled—by Hardy1, Sarnoff2, and Cordova and Feldman3. Their comments are academic criticism in the very best sense.We also take the opportunity to update on recent legal actions, whichwe had not predicted.This opportunity enriches our narrative history of the patenting of the APPswe mutation for early onset Alzheimer’s disease, and we hope the continued saga is of interest.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
